Li, H.; Li, J.-j.; Lu, W.; Yang, J.; Xia, Y.; Huang, P.
Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines 2023, 11, 475.
https://doi.org/10.3390/biomedicines11020475
AMA Style
Li H, Li J-j, Lu W, Yang J, Xia Y, Huang P.
Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines. 2023; 11(2):475.
https://doi.org/10.3390/biomedicines11020475
Chicago/Turabian Style
Li, He, Jiang-jiang Li, Wenhua Lu, Jing Yang, Yunfei Xia, and Peng Huang.
2023. "Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism" Biomedicines 11, no. 2: 475.
https://doi.org/10.3390/biomedicines11020475
APA Style
Li, H., Li, J.-j., Lu, W., Yang, J., Xia, Y., & Huang, P.
(2023). Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism. Biomedicines, 11(2), 475.
https://doi.org/10.3390/biomedicines11020475